Olfactory Disorders

• CLINICAL_TRIALS trial_result · 2025-07-25
  Clinical Trial Update: REEDUCATION OF OLFACTORY DISORDERS AFTER A CEREBRAL VASCULAR ACCIDENT IN ADULTS [NA]

  An investigation into reeducation of olfactory disorders following an adult stroke, with the trial currently terminated.

• CLINICAL_TRIALS trial_result · 2025-06-29
  Clinical Trial Update: Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection

  A completed clinical trial assessing olfactory dysfunction in COVID-19 patients, focusing on loss of smell and related quality-of-life impac…

• CLINICAL_TRIALS trial_result · 2025-04-22
  Clinical Trial Update: COVID-19: Post-covid Olfactory Disorders Assessment

  A completed clinical trial assessing post-COVID olfactory disorders (loss of smell).

• CLINICAL_TRIALS trial_result · 2025-03-04
  Clinical Trial Update: Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction [Phase 2]

  Phase 2 clinical trial evaluating gabapentin for post-COVID-19 olfactory dysfunction has completed and results have been posted.

• CLINICAL_TRIALS trial_result · 2024-02-12
  Clinical Trial Update: GnRH Therapy on Cognition in Down Syndrome [Phase 2, Phase 3]

  A Phase 2/3 clinical trial investigating GnRH therapy for cognitive decline in individuals with Down syndrome is currently recruiting.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2024-01-09
  Clinical Trial Update: Helping Olfaction and Nutrition On Renal Replacement [Phase 2]

  Phase 2 trial update for a study on improving sense of smell and nutrition in patients with renal failure.

• CLINICAL_TRIALS trial_result · 2010-02-09
  Clinical Trial Update: Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study [Phase 2]

  This phase 2 pilot study evaluates delta-9-tetrahydrocannabinol (Dronabinol) as an orexigenic therapy to improve appetite in advanced cancer…